Evidence map›Paper›PMID 32506220›Full record

ArticleJournal of cancer survivorship : research and practice2020

Looking under the hood of "the Cadillac of cancers:" radioactive iodine-related craniofacial side effects among patients with thyroid cancer.

Samantha A Diamond-Rossi, Jacqueline Jonklaas, Roxanne E Jensen, Charlene Kuo, Selma Stearns, Giuseppe Esposito, Bruce J Davidson, George Luta, Gary Bloom, Kristi D Graves

Abstract read
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. "No such thing as good cancer": a qualitative exploration of the experience of early-onset thyroid cancer in survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  7. Salivary, lacrimal and nasal (SALANS) measure to assess side effects following radioactive iodine treatment: development, psychometric properties, and factor structure.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Impact of Nasolacrimal Dysfunction in Thyroid Cancer Survivors.Thyroid : official journal of the American Thyroid Association · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samantha A Diamond-RossiDivision of Endocrinology, Georgetown University, Washington, DC, USA.
Jacqueline JonklaasDivision of Endocrinology, Georgetown University, Washington, DC, USA.
Roxanne E JensenOutcomes Research Branch, Health Care Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
Charlene KuoDepartment of Behavioral and Community Health, University of Maryland School of Public Health, College Park, MD, USA.
Selma StearnsDepartment of Behavioural Science and Health, University College London, London, UK.
Giuseppe EspositoDivision of Nuclear Medicine, Department of Radiology, MedStar Georgetown University Hospital, Washington, DC, USA.
Bruce J DavidsonDepartment of Otolaryngology-Head and Neck Surgery, MedStar Georgetown University Hospital, Georgetown University, Washington, DC, USA.
George LutaDepartment of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC, USA.
Gary BloomThyCa: Thyroid Cancer Survivors' Association, Inc., Olney, MD, USA.
Kristi D GravesDepartment of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. kdg9@georgetown.edu.ORCID 0000-0001-8808-1631

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI MARCUS S NOEL · 1990 to 2026
$71.5M
Institutional Career Development CoreKL2TR001432 · NCATS · GEORGETOWN UNIVERSITY · PI UMANS, JASON G · 2015 to 2024
$7.5M
Capturing the Impact of Craniofacial Damage after Radioiodine TherapyR01DE025822 · NIDCR · GEORGETOWN UNIVERSITY · PI GRAVES, KRISTI D., JONKLAAS, JACQUELINE · 2016 to 2020
$1.3M
Use of a decision aid to resolve uncertainty about radioactive iodine treatment in patients with intermediate-risk thyroid cancer: the Radiance trialUG3DE031248 · NIDCR · GEORGETOWN UNIVERSITY · PI GRAVES, KRISTI D., JONKLAAS, JACQUELINE · 2022 to 2023
$653k
NCATS NIH HHS KL2 TR001432NCI NIH HHS P30 CA051008NIDCR NIH HHS R01 DE025822NIDCR NIH HHS UG3 DE031248
6 · The paper itself

Abstract

purposeDespite having a generally favorable prognosis, differentiated thyroid cancer is known to have a significant, long-term impact on the quality of life of survivors. We wished to investigate short- and long-term effects among thyroid cancer survivors following radioactive iodine therapy.

methodsWe conducted eight focus groups (N = 47) to understand patients' experiences of short- and long-term effects after radioactive iodine treatment and the impact these treatment-related side effects had on patients' quality of life. We elicited responses regarding experiences with side effects following radioactive iodine treatment, particularly salivary, lacrimal, and nasal symptoms. We transcribed audiotapes and conducted qualitative analyses to identify codes and themes.

resultsWe identified eight broad themes from the qualitative analyses. Themes reflecting physical symptoms included dry mouth, salivary gland dysfunction, altered taste, eye symptoms such as tearing or dryness, and epistaxis. Psychosocial themes included lack of knowledge and preparation for treatment, regret of treatment, and distress that thyroid cancer is labeled as a "good cancer."

conclusionsThyroid cancer survivors reported a wide range of radioactive iodine treatment-related effects and psychosocial concerns that appear to reduce quality of life. The psychosocial concerns reported by participants underscore the significant unmet information and support needs prior to and following RAI treatment among individuals diagnosed with thyroid cancer. IMPLICATIONS FOR CANCER SURVIVORS: Future research is needed to help both patients and physicians understand the effect of radioactive iodine on quality of life, and to better assess the benefits versus the risks of radioactive iodine therapy.

Indexed as

Quality of LifeAdultAgedAged, 80 and overCancer SurvivorsCraniofacial AbnormalitiesFemaleHumansIodine RadioisotopesMaleMiddle AgedThyroid NeoplasmsXerostomiaIodine RadioisotopesBenefit/riskLacrimalQuality of lifeRadioiodineSalivarySymptomsThyroid cancer

Identifiers

PMID32506220
PMCPMC7578022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.